| 153.69 -3.64 (-2.31%) | 04-25 11:12 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 188.26 | 1-year : | 195.21 |
| Resists | First : | 161.18 | Second : | 167.13 |
| Pivot price | 156.71 |
|||
| Supports | First : | 151.54 | Second : | 126.08 |
| MAs | MA(5) : | 154.97  |
MA(20) : | 158.38 |
| MA(100) : | 162.98 |
MA(250) : | 159.3 |
|
| MACD | MACD : | -2.6 |
Signal : | -2.4 |
| %K %D | K(14,3) : | 39 |
D(3) : | 35.2 |
| RSI | RSI(14): 36.3 |
|||
| 52-week | High : | 171.05 | Low : | 142.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BBH ] has closed above bottom band by 26.1%. Bollinger Bands are 48.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 157.89 - 158.44 | 158.44 - 158.94 |
| Low: | 155.35 - 156.08 | 156.08 - 156.74 |
| Close: | 156.2 - 157.19 | 157.19 - 158.11 |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Tue, 23 Apr 2024
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Movies Canada
Mon, 15 Apr 2024
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Sun, 24 Mar 2024
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo New Zealand News
Thu, 29 Feb 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
Tue, 09 Jan 2024
Biotech ETFs Stage Solid Comeback at the Start of 2024 - Yahoo Finance
Mon, 08 Jan 2024
Will the VanEck Biotech ETF Boom in 2024? - Opto RoW
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|